Morning Research: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.

LONDON, September 24, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Monday, September 23, 2013, the S&P 500 ended the day at 1,701.84, down 0.47%; the Dow Jones Industrial Average closed at 15,401.38, down 0.32%; and the NASDAQ Composite finished at 3,765.29, down 0.25%. Shares in the healthcare sector ended on a mixed note, even as the broader market posted losses. The major movers in the sector included Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Orexigen Therapeutics Inc. (NASDAQ: OREX), MAKO Surgical Corporation (NASDAQ: MAKO), and Alere Inc. (NYSE: ALR). AAAResearchReports.com has released full comprehensive research on VRTX, OREX, MAKO, and ALR. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/

Shares in Vertex Pharmaceuticals Inc. edged lower on Monday, extending the losses from the previous trading session. The company's shares ended the day at $75.59, which is 0.74% lower than the previous day's price of $76.15. The company's shares vacillated between $74.94 and $76.74 during the trading session. A total of 3.25 million shares were traded, which is above the daily average volume of 2.14 million. Despite Monday's losses, Vertex Pharmaceuticals Inc.'s stock is trading above its 200-day moving average of $64.91. Additionally, the company's shares have fallen by 0.51% in the previous three months, compared to a gain of 6.87% in the S&P 500 during the same period. Download free report on VRTX upon registration at:

http://www.AAAResearchReports.com/VRTX092413.pdf

Orexigen Therapeutics Inc.'s stock gained 0.99% on Monday, reversing some of the losses from the previous trading session. The company's shares fluctuated between $6.53 and $6.70 before finishing the day at $6.61. A total of 0.92 million shares were traded, which is below the daily average volume of 1.21 million. The company's shares have gained 9.44% in the previous three months, outperforming the S&P 500 which has gained 6.87% during the same period. Furthermore, Orexigen Therapeutics Inc.'s stock is trading above its 200-day moving average of $6.18. OREX technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/OREX092413.pdf

On Monday, MAKO Surgical Corp.'s stock edged lower to close at $16.28, down 0.49% from the previous day's closing price of $16.36. The company's shares oscillated between $15.94 and $16.49 during the trading session. A total of 0.46 million shares were traded, which is below the daily average volume of 0.84 million. Despite Monday's pullback, the company's shares have surged 10.97% in the last one month and 38.44% in the previous three months, outperforming the S&P 500 which has gained 2.30% and 6.87% during the respective periods. Moreover, MAKO Surgical Corp.'s stock is trading above its 50-day and 200-day moving averages of $14.55 and $12.44, respectively. The free report on MAKO can be downloaded by signing up now at:

http://www.AAAResearchReports.com/MAKO092413.pdf

Alere Inc.'s stock edged higher on Monday, reversing some of the losses from the previous trading session. The company's shares traded between $31.36 and $31.98 before finishing the day 0.86% higher at $31.68. A total of 0.63 million shares were traded, which is at par with the daily average volume. The company's shares have surged 27.54% in the previous three months, compared to a gain of 6.87% in the S&P 500 during the same period. Further, Alere Inc.'s stock is trading above its 50-day and 200-day moving averages of $31.16 and $25.43, respectively. A free report on ALR can be accessed by registering at:

http://www.AAAResearchReports.com/ALR092413.pdf

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.AAAresearchreports.com

SOURCE AAA Research Reports